Tumour immunity: effector response to tumour and role of the microenvironment
Top Cited Papers
- 1 March 2008
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 371 (9614) , 771-783
- https://doi.org/10.1016/s0140-6736(08)60241-x
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Inflammation and cancerNature, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996